impower133 and caspian trials for extensive stage sclc
Published 4 years ago • 185 plays • Length 3:08Download video MP4
Download video MP3
Similar videos
-
7:20
small-cell lung cancer: the impower133 and caspian trials
-
4:40
emerging therapies for extensive stage sclc and caspian trial
-
4:34
discussion of impower133 and caspian trials
-
2:07
extensive-stage sclc: potential in the caspian trial
-
3:44
the caspian trial in extensive-stage sclc
-
5:22
chemoimmunotherapy for es sclc: impower133 trial
-
5:06
impower133 in sclc
-
6:32
the caspian versus impower133 regimen
-
6:37
caspian trial: durvalumab and chemotherapy in es-sclc
-
1:50
impower133: atezolizumab, carboplatin plus etoposide for sclc
-
4:57
chemoimmunotherapy for es sclc: caspian trial
-
8:11
first-line immunotherapy: impower133 regimen
-
1:43
updated results from the caspian trial of durvalumab plus chemo in sclc
-
2:07
dr. chen on the impact of the pivotal impower133 trial on sclc
-
6:33
a win for small–cell lung cancer: impower 133
-
3:31
expert comment: caspian trial of durvalumab in sclc | raffaele califano
-
2:35
atezo maintenance therapy improves survival in the impower133 trial of es-sclc
-
1:59
dr. lai on the results of the caspian trial in small cell lung cancer
-
5:23
atezolizumab carboplatin/etoposide for extensive-stage small cell lung cancer: impower133 update